论文信息 - A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy - 字舞流文

A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

Kimberly S. Long | A. Kalra | J. Still | S. Cote | K. Kacena | S. Bilic | G. Nomikos | Y. Chyung | R. Iarrobino | D. Barrett | Amy Place | L. Vrishabhendra